Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
Clinical trial NCT00739973 · COMPLETED
Trial details
- NCT number
- NCT00739973
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-05-01
- Enrollment
- 2694
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.